VeriSign, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VRS.F | VERTOZ.NS | GDDY | ODYSSEY.BO | CCSI | IIIV | |
|---|---|---|---|---|---|---|
| Market cap | 25.43B | 3.01B | 14.98B | 675.15M | 681.32M | 661.57M |
| P/E (TTM) | 35.4 | 11.0 | 16.3 | 18.3 | 7.5 | 65.6 |
| Forward P/E | 45.9 | — | 10.5 | 11.2 | 6.1 | 15.6 |
| Price/book | -12.5 | 1.4 | -104.2 | 1.1 | 16.4 | 1.2 |
| Dividend yield | 1.05% | 0.32% | — | 2.15% | — | — |
| 1-year change | +33.21% | −54.84% | −11.00% | −42.72% | +48.78% | −35.61% |
| Today | +1.69% | +11.80% | +4.29% | −8.81% | +2.99% | +4.85% |
The closest companies by business and industry (Software - Infrastructure). Prices may be delayed up to 15 min.
Latest news
All VRS.F news ›VeriSign, Inc. $VRSN Stock: Sumitomo Mitsui Trust Group Inc. Reduces Position
Read Our Latest Analysis on VRSN Shares of VRSN opened at $313.88 on Wednesday. The company has a market cap of $28.16 billion, a PE ratio of 32.95 and a beta of 0.66. The stock has a 50-day moving average price of $296.97 and a 200-day…
VeriSign officer proposes $989K sale of 3,256 shares
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue…
VeriSign’s Danny R. McPherson sells 3,256 shares
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease ReconAfrica Announces Grant of Stock Options to New Director Palantir…
Can VeriSign (NASDAQ:VRSN) Climb Higher After Its Latest Upgrade?
What Is Driving Morgan Stanley (NYSE:MS) Strong Quarterly Performance? How Is Goldman Sachs (NYSE:GS) Strengthening Its Market Leadership? How Is Bank of America (NYSE:BAC) Strengthening Its Banking Business? What Is Powering Cheniere…
VeriSign, Inc. (NASDAQ:VRSN) Stock Has Average Target Price of $348.00 According to Analysts
View Our Latest Stock Analysis on VRSN Here are the key news stories impacting VeriSign this week: Shares of VeriSign stock opened at $300.32 on Friday. VeriSign has a fifty-two week low of $208.86 and a fifty-two week high of $312.48. The…
VeriSign, Inc. $VRSN Stock: North Dakota State Investment Board Cuts Stake
Posted by Kim Johansen on Nov 1st, 2026 Shares of NASDAQ VRSN opened at $307.21 on Friday. The stock has a fifty day moving average price of $295.98 and a two-hundred day moving average price of $271.38. The firm has a market cap of $27.56…
VeriSign (NASDAQ:VRSN) Stock Price Target Raised at Wedbush
VeriSign (NASDAQ:VRSN - Get Free Report) had its price objective increased by stock analysts at Wedbush from $351.00 to $367.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has an "outperform" rating on…
VeriSign (NASDAQ:VRSN) versus Infosys (NYSE:INFY) Critical Review
Posted by Tristan Rich on Oct 31st, 2026 Infosys (NYSE:INFY – Get Free Report) and VeriSign (NASDAQ:VRSN – Get Free Report) are both large-cap technology companies, but which is the superior stock? We will contrast the two companies based…
VeriSign: 3 Key Takeaways for Long-Term Investors
Artificial intelligence software helps creators launch websites quickly, which boosts demand for domain names. Management increased its full-year 2026 domain base growth target to between 6.5% and 7% as customer demand picked up across key…
Financial Comparison: VeriSign (NASDAQ:VRSN) versus Applied Digital (NASDAQ:APLD)
Posted by Sarita Garza on Oct 26th, 2026 VeriSign (NASDAQ:VRSN – Get Free Report) and Applied Digital (NASDAQ:APLD – Get Free Report) are both technology companies, but which is the superior stock? We will compare the two companies based…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com19
- stocktitan.net8
- marketbeat.com7
- seekingalpha.com7
- themarketsdaily.com4
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 64 articles, not a forecast.